Back
Edgewise Therapeutics Stock Price Chart
Sponsored
EWTX
Sponsored
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
68
EWTX
Edgewise Therapeutics
Last Price:
30.17
Seasonality Move:
30.89%
7 Day Trial
ALL ACCESS PASS
$
7
This is an offer you won't want to refuse...
Hurry. Don't miss these two trades.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EWTX is experiencing selling pressure, which indicates risk of future bearish movement.
Edgewise Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 30.09 | Buy |
20-day SMA: | 31.24 | Sell |
50-day SMA: | 32.59 | Sell |
200-day SMA: | 22.17 | Buy |
8-day EMA: | 30.32 | Sell |
20-day EMA: | 31.1 | Sell |
50-day EMA: | 30.61 | Sell |
200-day EMA: | 23.35 | Buy |
Edgewise Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.67 | Sell |
Relative Strength Index (14 RSI): | 46.31 | Sell |
Chaikin Money Flow: | -1448657 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (29.94 - 33.12) | Sell |
Bollinger Bands (100): | (19.28 - 33.4) | Buy |
Edgewise Therapeutics Technical Analysis
Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Edgewise Therapeutics Stock
Is Edgewise Therapeutics Stock a Buy?
- Edgewise Therapeutics share price is 30.17 while EWTX 8-day simple moving average is 30.09, which is a Buy signal.
- The stock price of EWTX is 30.17 while Edgewise Therapeutics 20-day SMA is 31.24, which makes it a Sell.
- Edgewise Therapeutics 50-day simple moving average is 32.59 while EWTX share price is 30.17, making it a Sell technically.
- EWTX stock price is 30.17 and Edgewise Therapeutics 200-day simple moving average is 22.17, creating a Buy signal.
EWTX Technical Analysis vs Fundamental Analysis
Buy
68
Edgewise Therapeutics (EWTX)
is a Buy
Is Edgewise Therapeutics a Buy or a Sell?
-
Edgewise Therapeutics stock is rated a Buy
The current Edgewise Therapeutics [EWTX] share price is $30.17. The Score for EWTX is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
Edgewise Therapeutics Stock Info
Market Cap:
2.86B
Price in USD:
30.17
Share Volume:
1.64M
Edgewise Therapeutics 52-Week Range
52-Week High:
38.12
52-Week Low:
6.82
Buy
68
Edgewise Therapeutics (EWTX)
is a Buy
Edgewise Therapeutics Share Price Forecast
-
What is the Edgewise Therapeutics stock price today?
The Edgewise Therapeutics stock price is 30.17 USD today. -
Will EWTX stock go up or go down?
Edgewise Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Edgewise Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Edgewise Therapeutics is not overvalued.
Is Edgewise Therapeutics Stock a Buy?
- Edgewise Therapeutics share price is 30.17 while EWTX 8-day exponential moving average is 30.32, which is a Sell signal.
- The stock price of EWTX is 30.17 while Edgewise Therapeutics 20-day EMA is 31.10, which makes it a Sell.
- Edgewise Therapeutics 50-day exponential moving average is 30.61 while EWTX share price is 30.17, making it a Sell technically.
- EWTX stock price is 30.17 and Edgewise Therapeutics 200-day simple moving average is 23.35, creating a Buy signal.
Fundamental Analysis of Edgewise Therapeutics
Is Edgewise Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.04 per share, and a decrease next year of $0.30 per share.
Technical Analysis of Edgewise Therapeutics
Should I short Edgewise Therapeutics stock?
- EWTX Moving Average Covergence Divergence (MACD) indicator is -0.67, suggesting Edgewise Therapeutics is a Sell
- Edgewise Therapeutics Relative Strength Index (RSI) is 46.31, which suggest Edgewise Therapeutics is oversold
- The Bollinger Bands (25) for Edgewise Therapeutics is (29.94 - 33.12), which suggest Edgewise Therapeutics is a Buy
- The Bollinger Bands (100) for Edgewise Therapeutics is (19.28 - 33.4), which suggest Edgewise Therapeutics is a Buy
* Edgewise Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.